Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Massachusetts General Hospital
Research
ARPA-H awards up to $160M for custom genetic medicines
The most notable recipient is the Children’s Hospital of Philadelphia, which treated baby KJ with a groundbreaking custom gene therapy last year.
Darren Incorvaia
Jul 10, 2026 4:00am
Rival AbbVie and Denali prospects flunk phase 2/3 ALS tests
Jan 7, 2025 5:52am
Patient discharged with eGenesis’ CRISPR-edited pig kidney
Apr 4, 2024 12:27pm
AI tool predicts lung cancer risk in nonsmokers 6 years out
Jan 23, 2023 9:57am
Fujifilm picks up AI program for IVF procedures
Jun 24, 2022 11:38am
Fat could hold key to stem cell treatment for Parkinson's
May 31, 2022 7:30am
